HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)
HeartLung Receives FDA “Breakthrough” Designation and Marketing Authorization for the First AI to Enable Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans
Knowledge Center
AI-CAC improves on CAC for Cardiovascular Risk prediction: The Multi-Ethnic Study of Atherosclerosis
AI-enabled Cardiac Chambers Volumetry in Non-contrast Coronary Artery Calcium CT Scans vs. Contrast-Enhanced Coronary CT Angiography Scans in the Same Patients
AI-enabled Cardiac Chambers Volumetry in Coronary Artery Calcium (CAC) Scans (AI-CAC) Significantly Improves on Agatston CAC Score for Predicting All Cardiovascular Events:
Automated Left Ventricular Volumetry using Artificial Intelligence in Coronary Calcium Scans (AI-CAC) Predicts Heart Failure Comparably to Cardiac MRI and Outperforms NT-proBNP:
Coronary Artery Calcium Scans Powered by Artificial Intelligence (AI-CAC) Predicts Atrial Fibrillation and Stroke Comparably to Cardiac Magnetic Resonance Imaging:
AI-enabled Cardiac Chambers Volumetry in Non-Contrast Cardiac CT scans Detects HFrEF vs. HFpEF
AI-enabled automated bone mineral density measurement in coronary artery calcium scans (AutoBMD) is associated with high coronary artery calcium score independently of conventional risk factors:
AI-CVD: Artificial Intelligence-Enabled Opportunistic Screening of Coronary Artery Calcium ComputedTomography Scans for Predicting CVD Events and All-Cause Mortality:
AI-enabled Cardiac Chambers Volumetry in Coronary Artery Calcium (CAC) Scans (AI-CAC) vs. ASCVD Pooled Cohorts Equation and PREVENT Risk Scores:
Incorporating AI-enabled Left Atrial Volume Measurement from Coronary Artery Calcium Scans (AI-CAC) to CHA2DS2-VASc Risk Score Improves Stroke Prediction in the Asymptomatic Population:
Automated Left Ventricular Volumetry using Artificial Intelligence in Coronary Calcium Scans (AI-CAC) Predicts Heart Failure Comparably to Cardiac MRI and Outperforms NT-proBNP:
Coronary Artery Calcium Scans Powered by Artificial Intelligence (AI-CAC) Predicts Atrial Fibrillation and Stroke Comparably to Cardiac Magnetic Resonance Imaging:
Incorporating AI-enabled Left Atrial Volume Measurement from Coronary Artery Calcium Scans (AI-CAC) to CHADSs-VASc Risk Score Improves Stroke Prediction in the Asymptomatic Population:
AI-enabled Cardiac Chambers Volumetry in Coronary Artery Calcium (CAC) Scans (AI-CAC) vs. ASCVD Pooled Cohorts Equation and PREVENT Risk Scores: The Multi-Ethnic Study of Atherosclerosis
HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the Annual Scientific Sessions of the American Heart Association 2024
Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
HeartLung Technologies Receives FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™
The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis
Presented at ESC24 - Automated AI-Based Cardiac Chamber Volumetry: ECG-Gated Cardiac Scans vs. Non-Gated Lung Scans